Manulife (Manufacturers Life Insurance)’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-836
Closed -$3K 4304
2018
Q2
$3K Sell
836
-10,701
-93% -$38.4K ﹤0.01% 4188
2018
Q1
$73K Buy
11,537
+7,695
+200% +$48.7K ﹤0.01% 3485
2017
Q4
$31K Sell
3,842
-10,682
-74% -$86.2K ﹤0.01% 3682
2017
Q3
$166K Buy
14,524
+132
+0.9% +$1.51K ﹤0.01% 3124
2017
Q2
$141K Buy
14,392
+1,854
+15% +$18.2K ﹤0.01% 3250
2017
Q1
$304K Buy
12,538
+1,719
+16% +$41.7K ﹤0.01% 2539
2016
Q4
$347K Buy
10,819
+71
+0.7% +$2.28K ﹤0.01% 2372
2016
Q3
$537K Buy
10,748
+188
+2% +$9.39K ﹤0.01% 2036
2016
Q2
$448K Buy
10,560
+835
+9% +$35.4K ﹤0.01% 2106
2016
Q1
$623K Buy
9,725
+668
+7% +$42.8K ﹤0.01% 1854
2015
Q4
$563 Hold
9,057
﹤0.01% 1952
2015
Q3
$606 Buy
9,057
+245
+3% +$16 ﹤0.01% 1878
2015
Q2
$857 Buy
8,812
+563
+7% +$55 ﹤0.01% 1778
2015
Q1
$771 Buy
8,249
+300
+4% +$28 ﹤0.01% 1821
2014
Q4
$707 Sell
7,949
-286
-3% -$25 ﹤0.01% 1782
2014
Q3
$569 Buy
8,235
+221
+3% +$15 ﹤0.01% 1909
2014
Q2
$460K Sell
8,014
-1,434
-15% -$82.3K ﹤0.01% 2092
2014
Q1
$374 Sell
9,448
-307
-3% -$12 ﹤0.01% 2278
2013
Q4
$410 Buy
9,755
+691
+8% +$29 ﹤0.01% 2191
2013
Q3
$271 Sell
9,064
-405
-4% -$12 ﹤0.01% 2426
2013
Q2
$501K Buy
+9,469
New +$501K ﹤0.01% 1894